GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » Capex-to-Operating-Income

Cline Scientific AB (OSTO:CLINE B) Capex-to-Operating-Income : 18.60 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Cline Scientific AB's Capital Expenditure for the six months ended in Dec. 2023 was kr-4.46 Mil. Its Operating Income for the six months ended in Dec. 2023 was kr0.24 Mil.

Hence, Cline Scientific AB's Capex-to-Operating-Income for the six months ended in Dec. 2023 was 18.60.


Cline Scientific AB Capex-to-Operating-Income Historical Data

The historical data trend for Cline Scientific AB's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB Capex-to-Operating-Income Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only - - - - -

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 13.46 - 18.60

Competitive Comparison of Cline Scientific AB's Capex-to-Operating-Income

For the Biotechnology subindustry, Cline Scientific AB's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's Capex-to-Operating-Income falls into.


;
;

Cline Scientific AB Capex-to-Operating-Income Calculation

Cline Scientific AB's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.543) / -3.109
=N/A

Cline Scientific AB's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.464) / 0.24
=18.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cline Scientific AB  (OSTO:CLINE B) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Cline Scientific AB Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cline Scientific AB Business Description

Traded in Other Exchanges
N/A
Address
Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB Headlines

No Headlines